Downregulation of connective tissue growth factor by LPS/IFN-γ- induced nitric oxide is reversed by aristolochic acid treatment in glomerular mesangial cells via STAT-1α and NF-κB signaling

Chemico-Biological Interactions

Volumn 210, Issue 1, 2014, Pages 86-95

  Tsai, Kuen Daw ^c,d   Chen, Wei ^e   Wang, Sue Hong ^a,b   Hsiao, Yu Wei ^a,b   Chi, Jhih Ying ^a,b   Wu, Hsing Yu ^a,b   Lee, Yi Ju ^a   Wong, Ho Yiu ^c   Tseng, Min Jen ^d   Lin, Ting Hui ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

^d NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^e CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Aristolochic acid; Connective tissue growth factor; Glomerular mesangial cells; NF B; Nitric oxide; STAT 1

Indexed keywords

ARISTOLOCHIC ACID; CONNECTIVE TISSUE GROWTH FACTOR; GAMMA INTERFERON; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 1; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; STAT1 ALPHA PROTEIN; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ARISTOLOCHIC ACID NEPHROPATHY; ARTICLE; CELL LINE; CELL STRAIN MES 13; CONCENTRATION (PARAMETERS); DOWN REGULATION; ENZYME INDUCTION; GENE EXPRESSION; KIDNEY DISEASE; MESANGIUM CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ARISTOLOCHIC ACID; CONNECTIVE TISSUE GROWTH FACTOR; GLOMERULAR MESANGIAL CELLS; NF-ΚB; NITRIC OXIDE; STAT-1Α;

ARISTOLOCHIC ACIDS; CARCINOGENS; CELL LINE; CONNECTIVE TISSUE GROWTH FACTOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GLOMERULAR MESANGIUM; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR;

EID: 84893198225     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2013.12.017     Document Type: Article

References (41)

1. C. Bogdan Nitric oxide and the immune response Nat. Immunol. 2 2001 907 916
2. F. Aktan INOS-mediated nitric oxide production and its regulation Life Sci. 75 2004 639 653
3. U. Forstermann, and W.C. Sessa Nitric oxide synthases: regulation and function Eur. Heart J. 33 829-837 2012 837a-837d
4. B.C. Kone Nitric oxide in renal health and disease Am. J. Kidney Dis. 30 1997 311 333
5. H. de Jonge, and Y. Vanrenterghem Aristolochic acid: the common culprit of Chinese herbs nephropathy and Balkan endemic nephropathy Nephrol. Dial. Transplant. 23 2008 39 41
6. V.M. Arlt, M. Stiborova, J. vom Brocke, M.L. Simoes, G.M. Lord, J.L. Nortier, M. Hollstein, D.H. Phillips, and H.H. Schmeiser Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer Carcinogenesis 28 2007 2253 2261
7. J.L. Vanherweghem, M. Depierreux, C. Tielemans, D. Abramowicz, M. Dratwa, M. Jadoul, C. Richard, D. Vandervelde, D. Verbeelen, and R. Vanhaelen-Fastre et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs Lancet 341 1993 387 391
8. C.S. Yang, C.H. Lin, S.H. Chang, and H.C. Hsu Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs Am. J. Kidney Dis. 35 2000 313 318
9. I. Cicha, and M. Goppelt-Struebe Connective tissue growth factor: context-dependent functions and mechanisms of regulation Biofactors 35 2009 200 208
10. H. Ihn Pathogenesis of fibrosis: role of TGF-beta and CTGF Curr. Opin. Rheumatol. 14 2002 681 685
11. Y. Ito, J. Aten, R.J. Bende, B.S. Oemar, T.J. Rabelink, J.J. Weening, and R. Goldschmeding Expression of connective tissue growth factor in human renal fibrosis Kidney Int. 53 1998 853 861
12. M. Fragiadaki, A.S. Witherden, T. Kaneko, S. Sonnylal, C.D. Pusey, G. Bou-Gharios, and R.M. Mason Interstitial fibrosis is associated with increased COL1A2 transcription in AA-injured renal tubular epithelial cells in vivo Matrix Biol. 30 2011 396 403
13. C. Baylis Nitric oxide deficiency in chronic kidney disease Am. J. Physiol. Renal Physiol. 294 2008 F1 9
14. S. Klahr The role of nitric oxide in hypertension and renal disease progression Nephrol. Dial. Transplant. 16 Suppl. 1 2001 60 62
15. C.P. Verdon, B.A. Burton, and R.L. Prior Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite Anal. Biochem. 224 1995 502 508
16. C. Schindler, and J.E. Darnell Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway Annu. Rev. Biochem. 64 1995 621 651
17. Q.W. Xie, R. Whisnant, and C. Nathan Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide J. Exp. Med. 177 1993 1779 1784
18. T. Rein, M. Muller, and H. Zorbas In vivo footprinting of the IRF-1 promoter: inducible occupation of a GAS element next to a persistent structural alteration of the DNA Nucleic Acids Res. 22 1994 3033 3037
19. H. Kleinert, A. Pautz, K. Linker, and P.M. Schwarz Regulation of the expression of inducible nitric oxide synthase Eur. J. Pharmacol. 500 2004 255 266
20. J. Li, Z. Zhang, D. Wang, Y. Wang, Y. Li, and G. Wu TGF-beta 1/Smads signaling stimulates renal interstitial fibrosis in experimental AAN J. Recept. Signal Transduct. Res. 29 2009 280 285
21. F.D. Debelle, J.L. Nortier, C.P. Husson, E.G. De Prez, A.R. Vienne, K. Rombaut, I.J. Salmon, M.M. Deschodt-Lanckman, and J.L. Vanherweghem The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids Kidney Int. 66 2004 1815 1825
22. O. Lukivskaya, E. Patsenker, R. Lis, and V.U. Buko Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal Eur. J. Clin. Invest. 38 2008 317 325
23. F. Mihout, N. Shweke, N. Bige, C. Jouanneau, J.C. Dussaule, P. Ronco, C. Chatziantoniou, and J.J. Boffa Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-beta1 synthesis J. Pathol. 223 2011 37 45
24. H. Kikuchi, T. Katsuramaki, K. Kukita, S. Taketani, M. Meguro, M. Nagayama, M. Isobe, T. Mizuguchi, and K. Hirata New strategy for the antifibrotic therapy with oral administration of FR260330 (a selective inducible nitric oxide synthase inhibitor) in rat experimental liver cirrhosis Wound Repair Regen. 15 2007 881 888
25. M.G. Ferrini, D. Vernet, T.R. Magee, A. Shahed, A. Qian, J. Rajfer, and N.F. Gonzalez-Cadavid Antifibrotic role of inducible nitric oxide synthase Nitric Oxide 6 2002 283 294
26. J.J. Morrissey, S. Ishidoya, R. McCracken, and S. Klahr Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy J. Am. Soc. Nephrol. 7 1996 2202 2212
27. D. Hochberg, C.W. Johnson, J. Chen, D. Cohen, J. Stern, E.D. Vaughan Jr., D. Poppas, and D. Felsen Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase Lab. Invest. 80 2000 1721 1728
28. H. Trachtman, S. Futterweit, E. Pine, J. Mann, and E. Valderrama Chronic diabetic nephropathy: role of inducible nitric oxide synthase Pediatr. Nephrol. 17 2002 20 29
29. E. Dreieicher, K.F. Beck, S. Lazaroski, M. Boosen, W. Tsalastra-Greul, M. Beck, I. Fleming, L. Schaefer, and J. Pfeilschifter Nitric oxide inhibits glomerular TGF-beta signaling via SMOC-1 J. Am. Soc. Nephrol. 20 2009 1963 1974
30. A. Keil, I.E. Blom, R. Goldschmeding, and H.D. Rupprecht Nitric oxide down-regulates connective tissue growth factor in rat mesangial cells Kidney Int. 62 2002 401 411
31. J. Wani, M. Carl, A. Henger, P.J. Nelson, and H. Rupprecht Nitric oxide modulates expression of extracellular matrix genes linked to fibrosis in kidney mesangial cells Biol. Chem. 388 2007 497 506
32. S.H. Sims, Y. Cha, M.F. Romine, P.Q. Gao, K. Gottlieb, and A.B. Deisseroth A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter Mol. Cell. Biol. 13 1993 690 702
33. S. Vallabhapurapu, and M. Karin Regulation and function of NF-kappaB transcription factors in the immune system Annu. Rev. Immunol. 27 2009 693 733
34. Y.Y. Chen, S.Y. Chiang, H.C. Wu, S.T. Kao, C.Y. Hsiang, T.Y. Ho, and J.G. Lin Microarray analysis reveals the inhibition of nuclear factor-kappa B signaling by aristolochic acid in normal human kidney (HK-2) cells Acta Pharmacol. Sin. 31 2010 227 236
35. C.J. Wu, Y.C. Chou, Y.W. Cheng, C.J. Hsiao, C.H. Wang, H.Y. Wang, J.R. Sheu, and G. Hsiao Aristolochic acid downregulates monocytic matrix metalloproteinase-9 by inhibiting nuclear factor-kappaB activation Chem. Biol. Interact. 192 2011 209 219
36. M. Vivancos, and J.J. Moreno Role of Ca(2+)-independent phospholipase A(2) and cyclooxygenase/lipoxygenase pathways in the nitric oxide production by murine macrophages stimulated by lipopolysaccharides Nitric oxide 6 2002 255 262
37. M.D. Rosenthal, B.S. Vishwanath, and R.C. Franson Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils Biochim. Biophys. Acta 1001 1989 1 8
38. J.J. Moreno Effect of aristolochic acid on arachidonic acid cascade and in vivo models of inflammation Immunopharmacology 26 1993 1 9
39. Y.S. Lin, M. Hsieh, Y.J. Lee, K.L. Liu, and T.H. Lin AH23848 accelerates inducible nitric oxide synthase degradation through attenuation of cAMP signaling in glomerular mesangial cells Nitric Oxide 18 2008 93 104
40. Y.J. Ding, and Y.-H. Chen Developmental nephrotoxicity of aristolochic acid in a zebrafish model Toxicol. Appl. Pharmacol. 261 2012 59 65
41. S.M. Chen, M.Y. Fan, C.C. Tseng, Y. Ho, and K.Y. Hsu Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits Toxicon 50 2007 180 188